ProCE Banner Activity

Research Focus: Targeting CEACAM5 With Novel Antibody-Drug Conjugates in Nonsquamous Non-Small-Cell-Lung Cancer

Slideset

Downloadable slideset reviewing biomarker testing in advanced nonsquamous NSCLC, including CEACAM5 and the potential role of emerging antibody-drug conjugates targeting this biomarker.

Released: June 09, 2023

Share

Faculty

David Planchard

David Planchard, MD, PhD

Head of Thoracic Group
Department of Medical Oncology
Gustave Roussy
Villejuif, France

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi